Akhil Antony Konkoth/LinkedIn
Jul 15, 2026, 13:53
Akhil Antony Konkoth: Galectin-9 Emerges as a Key Mediator of Venous Thromboinflammation
Akhil Antony Konkoth, Research Fellow (BHF) in Cardiovascular Sciences at University of Birmingham, shared a post on LinkedIn:
“Very pleased to have presented my postdoctoral research at ISTH 2026 in Paris International Society on Thrombosis and Haemostasis (ISTH) on Galectin-9-mediated platelet activation and thromboinflammation in venous thrombosis.
I am sincerely grateful to my mentors, Asif Iqbal, Julie Rayes, Alexander Brill, and Ed Rainger for their invaluable guidance, support, and encouragement throughout this work.
It was a wonderful opportunity to share our findings, engage with researchers from around the world, and discuss the latest advances in thromboinflammation research.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day
-
Oct 17, 2026, 23:18Maha Othman: Establishing ISTH-BAT Reference Ranges for Children and Adolescents
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration